MARKET WIRE NEWS

MariMed Inc. (MRMD) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-08-07 22:24:11 ET

MariMed Inc. (MRMD)

Q2 2025 Earnings Conference Call

August 07, 2025, 08:00 AM ET

Company Participants

Jake Dean - Director of Research and Development

Jon R. Levine - Co-Founder, CEO, President, Secretary, Treasurer & Director

Mario Pinho - Chief Financial Officer

Ryan Crandall - Chief Commercial Officer

Conference Call Participants

Andrew Semple - Ventum Financial Corp., Research Division

Joseph Anthony Gomes - NOBLE Capital Markets, Inc., Research Division

Pablo Ernesto Zuanic - Zuanic & Associates

Presentation

Operator

Good morning. My name is Audra, and I will be your conference operator today. At this time, I would like to welcome everyone to the MariMed Inc. Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] I will now turn the line over to Jake Dean, Director of Research and Development. Please go ahead....

Read the full article on Seeking Alpha

For further details see:

MariMed Inc. (MRMD) Q2 2025 Earnings Call Transcript
MariMed Inc

NASDAQ: MRMD

MRMD Trading

2.43% G/L:

$0.0802 Last:

109,452 Volume:

$0.07666 Open:

mwn-alerts Ad 300

MRMD Latest News

MRMD Stock Data

$35,201,060
320,049,144
N/A
3
N/A
Pharmaceuticals
Healthcare
US
Norwood

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App